title: Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis.
authors.affiliation: MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, Hampshire, UK.|Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, UK.
authors.forename: S
authors.initials: S
authors.lastname: El-Heis
authors.affiliation: Department of Neurology, University Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, UK.
authors.forename: G
authors.initials: G
authors.lastname: Burke
authors.affiliation: Department of Neurology, University Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, UK.
authors.forename: W
authors.initials: W
authors.lastname: Gibb
authors.affiliation: Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, UK.|Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK.
authors.forename: M R
authors.initials: MR
authors.lastname: Ardern-Jones
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000009:adverse effects*; D000293:Adolescent; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D006801:Humans; D006945:Hyperhidrosis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced / Q000150:complications; D009465:Neuromuscular Agents / Q000009:adverse effects
chemical_list: D065087:Acetylcholine Release Inhibitors; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A